A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin-Reference-Cited by-同舟云学术

A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin

Published:2016-07 Issue:14 Volume:24 Page:3174-3183
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Vucicevic Jelica,Srdic-Rajic Tatjana,Pieroni Marco,Laurila Jonne M.M.,Perovic Vladimir,Tassini Sabrina,Azzali Elisa,Costantino Gabriele,Glisic Sanja,Agbaba Danica,Scheinin Mika,Nikolic Katarina,Radi Marco,Veljkovic Nevena

Funder

Ministry of Education, Science and Technological Development

University of Parma

Turku University Hospital

Chiesi Foundation

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference47 articles.

1. Imidazoline Receptors, Novel Agents and Therapeutic Potential

2. Contribution of imidazoline receptors and α2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine

3. Moxonidine modulates cytokine signalling and effects on cardiac cell viability

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the nischarin expression across human tumor types reveals its context-dependent role and a potential as a target for drug repurposing in oncology;PLOS ONE;2024-05-23

2. Harnessing Chemical Space Neural Networks to Systematically Annotate GPCR ligands;2024-04-01

3. Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability;European Journal of Medicinal Chemistry;2024-02

4. Advances in machine intelligence‐driven virtual screening approaches for big‐data;Medicinal Research Reviews;2023-12-21

5. Synthesis, Characterization, and In Vitro Anticancer Evaluation of 2-Aryl-4-Arylsulfonyl-5-RS-1,3-Oxazoles;BIOINTERFACE RES APP;2023